| Company | Revenue (Mar 2025) | Net Profit (Mar 2025) | EPS (Mar 2025) |
|---|---|---|---|
| Endurance Technologies | Rs 2,166.55 Cr | Rs 348.69 Cr | Rs 35.61 |
| Solar Industries | Rs 1,030.35 Cr | Rs 290.00 Cr | Rs 17.60 |
| GlaxoSmithKline | Rs 1,190.26 Cr | Rs -63.19 Cr | Rs -1.08 |
Endurance Technologies has demonstrated consistent financial performance over the past few quarters. The revenue has increased steadily, reaching Rs 2,166.55 Cr in March 2025 from Rs 1,610.71 Cr in March 2024. Similarly, the net profit has risen from Rs 240.15 Cr in March 2024 to Rs 348.69 Cr in March 2025. The EPS also shows an upward trend, increasing from Rs 25.98 to Rs 35.61 over the same period.
Solar Industries has also shown positive financial results. The revenue has grown from Rs 929.80 Cr in March 2024 to Rs 974.37 Cr in March 2025. The net profit has increased from Rs 194.48 Cr to Rs 262.87 Cr, and the EPS has risen from Rs 11.37 to Rs 15.52 over the same period.
In contrast, GlaxoSmithKline's financials reveal a different trajectory. While the revenue was Rs 1,174.83 Cr in March 2024, it decreased to Rs 1,030.35 Cr in March 2025. The net profit has declined from Rs 321.41 Cr to Rs 290.00 Cr, and the EPS has decreased from Rs 19.51 to Rs 17.60 over the same period.
Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal marked their presence among the top gainers in the NIFTY MIDCAP 150 during today's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.